1. Cross‐communication between histone H3 and H4 acetylation and Akt‐mTOR signalling in prostate cancer cells. Issue 7 (30th April 2014) Authors: Makarević, Jasmina; Tawanaie, Nassim; Juengel, Eva; Reiter, Michael; Mani, Jens; Tsaur, Igor; Bartsch, Georg; Haferkamp, Axel; Blaheta, Roman A. Journal: Journal of cellular and molecular medicine Issue: Volume 18:Issue 7(2014) Page Start: 1460 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CT-guided nephrostomy–An expedient tool for complex clinical scenarios. Issue 110 (January 2019) Authors: Brandt, Maximilian Peter; Lehnert, Thomas; Czilwik, Theresa; Borgmann, Hendrik; Gruber-Rouh, Tatjana; Thalhammer, Axel; Adam, Elisabeth Hannah; Thomas, Christian; Bartsch, Georg; Haferkamp, Axel; Vogl, Thomas Joseph; Tsaur, Igor Journal: European journal of radiology Issue: Issue 110(2019) Page Start: 142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Expression profiling for bladder cancer: strategies to uncover prognostic factors. Issue 12 (December 2010) Authors: Bartsch, Georg; Mitra, Anirban P; Cote, Richard J Journal: Expert review of anticancer therapy Issue: Volume 10:Issue 12(2010) Page Start: 1945 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. HDAC inhibition suppresses bladder cancer cell adhesion to collagen under flow conditions. (November 2013) Authors: Juengel, Eva; Santos, Sascha Meyer dos; Schneider, Tanja; Makarević, Jasmina; Hudak, Lukasz; Bartsch, Georg; Haferkamp, Axel; Wiesner, Christoph; Blaheta, Roman A Journal: Experimental biology and medicine Issue: Volume 238:Number 11(2013) Page Start: 1297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Improving selection of appropriate urinary diversion following radical cystectomy for bladder cancer. Issue 6 (June 2011) Authors: Daneshmand, Siamak; Bartsch, Georg Journal: Expert review of anticancer therapy Issue: Volume 11:Issue 6(2011) Page Start: 941 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Improving selection of appropriate urinary diversion following radical cystectomy for bladder cancer. Issue 6 (June 2011) Authors: Daneshmand, Siamak; Bartsch, Georg Journal: Expert review of anticancer therapy Issue: Volume 11:Issue 6(2011) Page Start: 941 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Improving selection of appropriate urinary diversion following radical cystectomy for bladder cancer. Issue 6 (June 2011) Authors: Daneshmand, Siamak; Bartsch, Georg Journal: Expert review of anticancer therapy Issue: Volume 11:Issue 6(2011) Page Start: 941 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Incidence, Risk Factors and Management of Symptomatic Lymphoceles after Radical Retropubic Prostatectomy. Issue 6 (November 2017) Authors: Thomas, Christian; van de Plas, Jeoren; Tsaur, Igor; Neisius, Andreas; Bartsch, Georg; Frees, Sebastian; Borgmann, Hendrik; Jäger, Wolfgang; Brandt, Maximilian Peter; Haferkamp, Axel; Rubenwolf, Peter Journal: Urology practice Issue: Volume 4:Issue 6(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Intensified antineoplastic effect by combining an HDAC‐inhibitor, an mTOR‐inhibitor and low dosed interferon alpha in prostate cancer cells. Issue 8 (26th March 2015) Authors: Tsaur, Igor; Hudak, Lukasz; Makarević, Jasmina; Juengel, Eva; Mani, Jens; Borgmann, Hendrik; Gust, Kilian M.; Schilling, David; Bartsch, Georg; Nelson, Karen; Haferkamp, Axel; Blaheta, Roman A. Journal: Journal of cellular and molecular medicine Issue: Volume 19:Issue 8(2015) Page Start: 1795 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Molecular analysis of sunitinib resistant renal cell carcinoma cells after sequential treatment with RAD001 (everolimus) or sorafenib. Issue 2 (2nd December 2014) Authors: Juengel, Eva; Kim, Dana; Makarević, Jasmina; Reiter, Michael; Tsaur, Igor; Bartsch, Georg; Haferkamp, Axel; Blaheta, Roman A. Journal: Journal of cellular and molecular medicine Issue: Volume 19:Issue 2(2015) Page Start: 430 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗